Bngo
14時間前
"before or by April",
Elite Pharmaceuticals’ Merger, Acquisition, or Up-listed on the NASDAQ Coming Soon.,
Listen to Elite’s most recent conference call and pay special attention to the last 10 minutes.,
It is very positive, uplifting, and motivating with merger, acquisition, or up-listed plan onto the NASDAQ.,
CEO Nasrat is working on it now telling all his contacts that Elite is for sale and is ready for acquisition or willing to merge with another pharmaceuticals company.,
Generic Percocet is going to be launched in less than 4 days,~$500 Million market,More revenue, better EPS,
Elite is a very well run company and has been cash flow positive for the past 5+ years.,
Here are Elite's past fiscal yearly revenue:,
2025: ?$75 Million+?,
2024: $56.62 Million,
2023: $34.15 Million,
2022: $32.26 Million,
2021: $25.38 Million,
2020: $17.99 Million,
2019: $7.56 Million
Here are some receipts of their great accomplishments so far
Good luck to all you long, strong, and loyal ELTP investors out there.We are going to be much richer very soon.,
I trust Nasrat and his team will get us there.,
Hopefully we all get to meet in Vegas or Hawaii to celebrate soon.,
1. Methotrexate launched on 8/27/24,~ $63 Million market,
https://elite.irpass.com/Elite-Pharmaceuticals-Announces-Commercial-Launch-of-Generic-Methotrexate-Sodium-8-27-2024,
2. Codeine with acetaminophen launched on 10/7/24, ~ $47 Million market,
https://elite.irpass.com/Elite-Pharmaceuticals-Announces-Commercial-Launch-of-Acetaminophen-and-Codeine-Phosphate-Tablets-10-7-2024,
3. Hydrocodone with acetaminophen launched on 12/2/24,~$300 Million market,
https://elite.irpass.com/irpass.asp?ResLibraryID=140659&BzID=2258&L=1&s=0&G=939&Nav=0,
4. Generic Vyvanse launched on 12/26/24, ~ $4.3 Billion martket,
https://elite.irpass.com/irpass.asp?ResLibraryID=141273&BzID=2258&L=1&s=0&G=939&Nav=0,
5. Elite Pharmaceuticals, Inc. Announces First Shipment Of Product From New Facility And Packaging Line,
https://elite.irpass.com/profiles/investor/ResLibraryView.asp?ResLibraryID=143102&BzID=2258&g=939&Nav=0&LangID=1&s=0
6. Opioid Abuse Deterrent Technology,https://elitepharma.com/technology-overview/
https://elitepharma.com/technology-overview/
Many catalysts are on deck to fuel ELTP to rocket up again.,
1. Launch of generic Percocet in less than 4 days,~$500 million market,
2. Launch of generic Dolophine (methadone) ~before or on 5/30/25, ~$30 million market,
3. Pending acquisition and merger news,
4. Pending generic Adderall IR launch in Israel,
5. Pending positive ruling for Elite with generic OxyContin,
6. Record breaking quarterly revenue report on 6/30/25,
7. April 1 - Elite terminates Prasco Agreement and begins marketing Adderall XR 100% by themselves,
8. April 2 - Tariffs begin - wild card for merger/acquisition, most likely to contribute an added premium to our acquisition price,
Eli Lilly to spend up to $27 billion in new domestic plants amid Trump tariff threat,
https://www.cnbc.com/amp/2025/02/26/eli-lilly-to-invest-27-billion-in-new-us-manufacturing.html
J&J boosts US investments by 25% over 4 years amid looming tariff threats | Reuters,
https://www.cnbc.com/amp/2025/03/21/jj-boosts-investments-in-us-to-more-than-55-billion-amid-looming-tariff-threats-.html
9. Pending Dopamine Agonist approval,
10. Pending India R&D Agreement signed,
11. Pending Positive BE studies (Concerta and Undisclosed),~$1.2 Billion market,
https://fullratio.com/pe-ratio-by-industry,
Share Price = EPS x P/E Ratio,
$0.2172 = $.01 x 21.72,
$0.4344 = $.02 x 21.72,
$0.6516 = $.03 x 21.72,
$0.8688 = $.04 x 21.72,
$1.0860 = $.05 x 21.72,
$1.3032 = $.06 x 21.72,
$1.5204 = $.07 x 21.72,
$1.7376 = $.08 x 21.72,
$1.9548 = $.09 x 21.72,
$2.1720 = $.10 x 21.72,
Elite Pharmaceuticals was listed in all 4 recent articles with Apple stock app.,
February 2025 Penny Stocks To Keep An Eye Onhttps://stocks.apple.com/Ah9N4nOg_ShisgYYtddapjQ
3 Promising Penny Stocks Below $500M Market Cap,https://stocks.apple.com/AFW8crl7LSt-kNf2QgI1BYA
US Penny Stocks To Watch In November 2024,https://stocks.apple.com/A_kvAJIyeQ7SiwuErhr-tyQ
3 Promising Penny Stocks On US Exchanges With Over $600M Market Cap,https://stocks.apple.com/AQxaED0BeSTqmWev2Z85VvQ
Bngo
15時間前
Generic Percocet is going to be launched in less than 4 days.~$500 Million marketMore revenue, better EPS
Why do you like to continue to bash Elite Pharmaceuticals?
See all the positive things that Nasrat and his team have done all these years to take care of their employees to have good jobs and bringing more value for shareholders.
Elite is a very well run company and has been cash flow positive for the past 5+ years.
Here are Elite's past fiscal yearly revenue.
2025: ?$75 Million+?,
2024: $56.62 Million 2023: $34.15 Million2022: $32.26 Million2021: $25.38 Million 2020: $17.99 Million2019: $7.56 Million
Try to see the positive and not stew in your negative energy and outlook on Elite Pharmaceuticals.
It is not good for your health and well being.
You will never get ahead in life tearing good people down for your own gains.
Here are some receipts of their great accomplishments so far and aspire to do the same in your daily life and maybe you one day you can be a multi-millionaire like Nasrat if you are wiling to change your ways with a positive mental attitude.
Good luck to all you long, strong, and loyal ELTP investors out there.We are going to be much richer very soon. I trust Nasrat and his team will get us there. Hopefully we all get to meet in Vegas or Hawaii to celebrate soon.
1. Methotrexate launched on 8/27/24 ~ $63 Million market
https://elite.irpass.com/Elite-Pharmaceuticals-Announces-Commercial-Launch-of-Generic-Methotrexate-Sodium-8-27-2024
2. Codeine with acetaminophen launched on 10/7/24 ~ $47 Million market
https://elite.irpass.com/Elite-Pharmaceuticals-Announces-Commercial-Launch-of-Acetaminophen-and-Codeine-Phosphate-Tablets-10-7-2024
3. Hydrocodone with acetaminophen launched on 12/2/24 ~$300 Million market
https://elite.irpass.com/irpass.asp?ResLibraryID=140659&BzID=2258&L=1&s=0&G=939&Nav=0
4. Generic Vyvanse launched on 12/26/24 ~ $4.3 Billion martket
https://elite.irpass.com/irpass.asp?ResLibraryID=141273&BzID=2258&L=1&s=0&G=939&Nav=0
5. Elite Pharmaceuticals, Inc. Announces First Shipment Of Product From New Facility And Packaging Line
https://elite.irpass.com/profiles/investor/ResLibraryView.asp?ResLibraryID=143102&BzID=2258&g=939&Nav=0&LangID=1&s=0
6. Opioid Abuse Deterrent Technologyhttps://elitepharma.com/technology-overview/
https://elitepharma.com/technology-overview/
Many catalysts are on deck to fuel ELTP to rocket up again.
1. Launch of generic Percocet in less than 4 days.~$500 million market
2. Launch of generic Dolophine (methadone) ~before or on 5/30/25 ~$30 million market
3. Pending acquisition and merger news
4. Pending generic Adderall IR launch in Israel
5. Pending positive ruling for Elite with generic OxyContin
6. Record breaking quarterly revenue report on 6/30/25
7. April 1 - Elite terminates Prasco Agreement and begins marketing Adderall XR 100% by themselves
8. April 2 - Tariffs begin - wild card for merger/acquisition, most likely to contribute an added premium to our acquisition price
Eli Lilly to spend up to $27 billion in new domestic plants amid Trump tariff threat
https://www.cnbc.com/amp/2025/02/26/eli-lilly-to-invest-27-billion-in-new-us-manufacturing.html
J&J boosts US investments by 25% over 4 years amid looming tariff threats | Reuters
https://www.cnbc.com/amp/2025/03/21/jj-boosts-investments-in-us-to-more-than-55-billion-amid-looming-tariff-threats-.html
9. Pending Dopamine Agonist approval
10. Pending India R&D Agreement signed
11. Pending Positive BE studies (Concerta and Undisclosed)~$1.2 Billion market
https://fullratio.com/pe-ratio-by-industry
Share Price = EPS x P/E Ratio$0.2172 = $.01 x 21.72,
$0.4344 = $.02 x 21.72,
$0.6516 = $.03 x 21.72,
$0.8688 = $.04 x 21.72,
$1.0860 = $.05 x 21.72,
$1.3032 = $.06 x 21.72,
$1.5204 = $.07 x 21.72,
$1.7376 = $.08 x 21.72,
$1.9548 = $.09 x 21.72,
$2.1720 = $.10 x 21.72,
Elite Pharmaceuticals was listed in all 4 recent articles with Apple stock app.
February 2025 Penny Stocks To Keep An Eye Onhttps://stocks.apple.com/Ah9N4nOg_ShisgYYtddapjQ
3 Promising Penny Stocks Below $500M Market Caphttps://stocks.apple.com/AFW8crl7LSt-kNf2QgI1BYA
US Penny Stocks To Watch In November 2024https://stocks.apple.com/A_kvAJIyeQ7SiwuErhr-tyQ
3 Promising Penny Stocks On US Exchanges With Over $600M Market Caphttps://stocks.apple.com/AQxaED0BeSTqmWev2Z85VvQ